Case Study Analysis Paper 2
Healthcare

Write a word paper that analyzes the two leadership case studies found in the topic materials for this module, “Coach Knight: A Will to Win” and

“Coach K: A Matter of the Heart.”

Address the following questions and concepts:

Based on the models of Robert Katz and Michael D. Mumford and colleagues, which skills do you think accounted for the success of Coach K and Coach

Knight? Which skills appear to be deficient?
Compare and contrast Coach K’s and Coach Knight’s leadership styles using Blake and Mouton’s leadership grid. How are they similar? How are they

different? Are they both effective? Why or why not?

Healthcare

Required Reading:

Eon van der, M. S., & Bredenkamp, J. (2013). Originator and generic medicine: Pricing and market share. International Journal of Pharmaceutical and Healthcare Marketing, 7(2), 104-119.
Gandjour, A. (2013). Reference pricing and price negotiations for innovative new drugs: Viable policies in the long term? PharmacoEconomics, 31(1), 11-4.

Jones, J.D. (2003). Developing an effective generic prescription drug program. Benefits Quarterly, 19(1): 14-18.

Kaló, Z., Annemans, L., & Garrison, L. P. (2013). Differential pricing of new pharmaceuticals in lower income European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 13(6), 735-41.

Kramer, D. B., & Kesselheim, Aaron S,. (2013). The medical device excise tax — over before it begins? The New England Journal of Medicine, 368(19), 1767-9.

Monasterio, E., & Gleeson, D. (2014). Pharmaceutical industry behaviour and the trans pacific partnership agreement. The New Zealand Medical Journal (Online), 127(1389), 6-12.

Sorenson, C., Drummond, M., & Burns, L. R. (2013). Evolving reimbursement and pricing policies for devices in europe and the united states should encourage greater value. Health Affairs, 32(4), 788-96.

Sussex, J., Towse, A., & Devlin, N. (2013). Operationalizing value-based pricing of medicines: A taxonomy of approaches. PharmacoEconomics, 31(1), 1-10.

Wu, J., Xu, J., Liu, G., & Wu, J. (2014). Pharmaceutical pricing: An empirical study of market competition in Chinese hospitals. PharmacoEconomics, 32(3), 293-303.

Assignment:

1. Describe a Banner University of Arizona Medical Center (Tucson Arizona) pricing strategy for one of its services or products (e.g., a pharmaceutical drug or a medical device).

2. Explain how costs would be taken into account when formulating that pricing strategy.

Healthcare

Required Reading:

Eon van der, M. S., & Bredenkamp, J. (2013). Originator and generic medicine: Pricing and market share. International Journal of Pharmaceutical and Healthcare Marketing, 7(2), 104-119.
Gandjour, A. (2013). Reference pricing and price negotiations for innovative new drugs: Viable policies in the long term? PharmacoEconomics, 31(1), 11-4.

Jones, J.D. (2003). Developing an effective generic prescription drug program. Benefits Quarterly, 19(1): 14-18.

Kaló, Z., Annemans, L., & Garrison, L. P. (2013). Differential pricing of new pharmaceuticals in lower income European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 13(6), 735-41.

Kramer, D. B., & Kesselheim, Aaron S,. (2013). The medical device excise tax — over before it begins? The New England Journal of Medicine, 368(19), 1767-9.

Monasterio, E., & Gleeson, D. (2014). Pharmaceutical industry behaviour and the trans pacific partnership agreement. The New Zealand Medical Journal (Online), 127(1389), 6-12.

Sorenson, C., Drummond, M., & Burns, L. R. (2013). Evolving reimbursement and pricing policies for devices in europe and the united states should encourage greater value. Health Affairs, 32(4), 788-96.

Sussex, J., Towse, A., & Devlin, N. (2013). Operationalizing value-based pricing of medicines: A taxonomy of approaches. PharmacoEconomics, 31(1), 1-10.

Wu, J., Xu, J., Liu, G., & Wu, J. (2014). Pharmaceutical pricing: An empirical study of market competition in Chinese hospitals. PharmacoEconomics, 32(3), 293-303.

Assignment:

1. Describe a Banner University of Arizona Medical Center (Tucson Arizona) pricing strategy for one of its services or products (e.g., a pharmaceutical drug or a medical device).

2. Explain how costs would be taken into account when formulating that pricing strategy.